FDA issued a Warning Letter to KRS Global Biotechnology, Inc on 7/6/2015 for a previous inspection.
483 KRS Global Biotechnology Oct 2017

483 KRS Global Biotechnology Oct 2017

Jennifer Lalama FDA$119.00 - Available Now

FDA investigators audited the KRS Global Biotechnology - Boca Raton, FL, United States facility and issued inspectional observations (via FDA 483) on 23 Oct 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 23 Oct 2017
  • Location: Boca Raton, United States
  • FEI: 3006412304
Add To Cart